Our Targeted Translation Research Accelerator (TTRA) program, a Medical Research Future Fund initiative will open Round 3 of its Research Projects funding opportunity in early 2023 to support diabetes and cardiovascular disease projects that address the unmet health and medical needs of Aboriginal and Torres Strait Islander peoples in rural, remote, regional, and urban centres.
A prioritisation project to determine the Indigenous-specific priority areas for this round is currently underway, led by the Lowitja Institute, a community-controlled organisation and Australia’s National Institute for Aboriginal and Torres Strait Islander Health Research.
In anticipation of the round, MTPConnect hosted a webinar to highlight key elements of Aboriginal and Torres Strait Islander health research that potential applicants should consider early when building their projects and teams.
During the webinar, we heard from three outstanding Indigenous researchers, all dedicated to ensuring that Aboriginal and Torres Strait Islander health research is conducted by community, for community with a long-lasting impact on health and wellbeing.
Speakers:
See the TTRA Round 3 webpage for more information.